Neil Cockburn
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Neil Cockburn has a total of 128 co-authors. Here are the top co-authors by number of shared publications:
- Krishnarajah Nirantharakumar
Institute of Applied Health Research, University of Birmingham, Birmingham, UK
6 shared publications - Gillian Santorelli
Bradford Health Data Science Bradford England BD96RJ Bradford Institute for Health Research
5 shared publications - Sinead Brophy
Swansea University
5 shared publications - Anuradhaa Subramanian
Institute of Applied Health Research, University of Birmingham College of Medical and Dental Sciences, Birmingham, UK
4 shared publications Joht Singh Chandan
4 shared publications- Katherine Phillips
University of Birmingham
4 shared publications
Latest Publications
- Open Access
- 12 November 2026
- Published by Elsevier in The Lancet Primary Care
Health-care-recorded involvement in sex work and health outcomes in primary and secondary care in England: a retrospective cohort study
- 12 November 2026
- Published by Elsevier in The Lancet Primary Care
Open AccessHealth-care-recorded involvement in sex work and health outcomes in primary and secondary care in England: a retrospective cohort study
- Open Access
- 23 September 2026
- Published by Elsevier in The Lancet Regional Health - Europe
- Vol. 70
Divergent pandemic responses in miscarriage and ectopic pregnancy admissions
- 23 September 2026
- Published by Elsevier in The Lancet Regional Health - Europe
- Vol. 70
Open AccessDivergent pandemic responses in miscarriage and ectopic pregnancy admissions
- Open Access
- 21 May 2026
- Published by Springer Nature in BMC Medicine
- Vol. 24 (1)
Autoimmune diseases and risk of adverse pregnancy outcomes: a population-based cohort study of five million pregnancies in the UK
Background: With an increasing trend in the prevalence of maternal autoimmune diseases in pregnancy, there is need for evidence on the association between autoimmune diseases and pregnancy outcomes. Methods: This population-based cohort study used data on pregnancies from primary care practices that contributed to the UK Clinical Practice Research Datalink (CPRD) database (Gold and Aurum) between 2000 and 2022, linked to Hospital Episode Statistics (HES). Modified Poisson regression with robust standard errors estimated adjusted relative risks (aRR) and 95% confidence intervals (95% CI) assessing the association between 17 autoimmune diseases and 12 pregnancy outcomes, selected following literature review and expert consultation. Models were adjusted for demographic and comorbidity variables. Findings were evaluated using the Benjamini–Yekutieli procedure to control for multiple testing across autoimmune disease–outcome associations. Results: A total of 5,239,383 pregnancies from the CPRD pregnancy register and 2,485,366 births recorded in HES maternity data met the eligibility criteria. Women with autoimmune diseases had an increased risk across all pregnancy outcomes examined. Among antenatal outcomes, markedly elevated risks were observed for hyperemesis gravidarum in Addison’s disease (aRR 3.72, 95% CI 2.48–5.59), miscarriage in Sjögren’s syndrome (1.66, 1.02–2.70), gestational hypertension in type 1 diabetes mellitus (T1DM; 2.95, 2.77–3.15), pre-eclampsia/eclampsia in T1DM (3.56, 3.32–3.82), and gestational diabetes mellitus in Graves’ disease (1.37, 1.21–1.54). For obstetric outcomes, increased risks were observed for caesarean birth in inflammatory bowel disease (IBD; 1.27, 1.22–1.31), small for gestational age in systemic lupus erythematosus (SLE; 2.45, 1.65–3.62), preterm birth in rheumatoid arthritis (1.53, 1.33–1.76), and stillbirth in SLE (1.82, 1.12–1.84). Perinatal mental health outcomes were more common across several autoimmune diseases, with particularly high risks in myasthenia gravis (anxiety 3.05, 1.89–4.92; depression 1.77, 1.37–2.28), SLE (anxiety 2.11, 1.67–2.67; depression 1.36, 1.22–1.53), and multiple sclerosis (anxiety 1.76, 1.38–2.23; depression 1.94, 1.77–2.12). Inverse associations were observed for hyperemesis gravidarum in systemic sclerosis, SLE, and myasthenia gravis, and for hypertensive disorders of pregnancy in multiple sclerosis. After Benjamini–Yekutieli correction for multiple testing, the number of statistically significant associations was reduced, with a core set of robust associations persisting across selected autoimmune diseases particularly, T1DM, SLE, Graves’ disease, IBD and key pregnancy outcomes. Conclusions: Autoimmune diseases were associated with increased risks across a wide range of adverse pregnancy outcomes, with marked heterogeneity between individual conditions. This study provides adjusted relative risks across multiple domains of pregnancy outcomes including antenatal (e.g. miscarriage, hyperemesis gravidarum, gestational hypertension, pre-eclampsia, gestational diabetes), obstetric (e.g. preterm birth, caesarean birth, small for gestational age, stillbirth), and perinatal mental health outcomes (anxiety and depression), for both common and less frequently studied autoimmune diseases. The findings highlight the importance of disease-specific evaluation of pregnancy risks.
- 21 May 2026
- Published by Springer Nature in BMC Medicine
- Vol. 24 (1)
Open AccessAutoimmune diseases and risk of adverse pregnancy outcomes: a population-based cohort study of five million pregnancies in the UK
Background: With an increasing trend in the prevalence of maternal autoimmune diseases in pregnancy, there is need for evidence on the association between autoimmune diseases and pregnancy outcomes. Methods: This population-based cohort study used data on pregnancies from primary care practices that contributed to the UK Clinical Practice Research Datalink (CPRD) database (Gold and Aurum) between 2000 and 2022, linked to Hospital Episode Statistics (HES). Modified Poisson regression with robust standard errors estimated adjusted relative risks (aRR) and 95% confidence intervals (95% CI) assessing the association between 17 autoimmune diseases and 12 pregnancy outcomes, selected following literature review and expert consultation. Models were adjusted for demographic and comorbidity variables. Findings were evaluated using the Benjamini–Yekutieli procedure to control for multiple testing across autoimmune disease–outcome associations. Results: A total of 5,239,383 pregnancies from the CPRD pregnancy register and 2,485,366 births recorded in HES maternity data met the eligibility criteria. Women with autoimmune diseases had an increased risk across all pregnancy outcomes examined. Among antenatal outcomes, markedly elevated risks were observed for hyperemesis gravidarum in Addison’s disease (aRR 3.72, 95% CI 2.48–5.59), miscarriage in Sjögren’s syndrome (1.66, 1.02–2.70), gestational hypertension in type 1 diabetes mellitus (T1DM; 2.95, 2.77–3.15), pre-eclampsia/eclampsia in T1DM (3.56, 3.32–3.82), and gestational diabetes mellitus in Graves’ disease (1.37, 1.21–1.54). For obstetric outcomes, increased risks were observed for caesarean birth in inflammatory bowel disease (IBD; 1.27, 1.22–1.31), small for gestational age in systemic lupus erythematosus (SLE; 2.45, 1.65–3.62), preterm birth in rheumatoid arthritis (1.53, 1.33–1.76), and stillbirth in SLE (1.82, 1.12–1.84). Perinatal mental health outcomes were more common across several autoimmune diseases, with particularly high risks in myasthenia gravis (anxiety 3.05, 1.89–4.92; depression 1.77, 1.37–2.28), SLE (anxiety 2.11, 1.67–2.67; depression 1.36, 1.22–1.53), and multiple sclerosis (anxiety 1.76, 1.38–2.23; depression 1.94, 1.77–2.12). Inverse associations were observed for hyperemesis gravidarum in systemic sclerosis, SLE, and myasthenia gravis, and for hypertensive disorders of pregnancy in multiple sclerosis. After Benjamini–Yekutieli correction for multiple testing, the number of statistically significant associations was reduced, with a core set of robust associations persisting across selected autoimmune diseases particularly, T1DM, SLE, Graves’ disease, IBD and key pregnancy outcomes. Conclusions: Autoimmune diseases were associated with increased risks across a wide range of adverse pregnancy outcomes, with marked heterogeneity between individual conditions. This study provides adjusted relative risks across multiple domains of pregnancy outcomes including antenatal (e.g. miscarriage, hyperemesis gravidarum, gestational hypertension, pre-eclampsia, gestational diabetes), obstetric (e.g. preterm birth, caesarean birth, small for gestational age, stillbirth), and perinatal mental health outcomes (anxiety and depression), for both common and less frequently studied autoimmune diseases. The findings highlight the importance of disease-specific evaluation of pregnancy risks.
- Open Access
Mother-infant linked UK electronic birth cohorts representing 17.5 million births harmonised to the OMOP common data model
We describe the harmonisation of five UK electronic birth cohorts to the Observational Medical Outcomes Partnership (OMOP) Common Data Model, creating a large-scale, standardised resource for maternal and child health research. The Mother and Infant Research Data Analysis (MIREDA) partnership developed and implemented reproducible guidelines for mapping maternal–infant relationships and identifying pregnancy episodes within routinely collected healthcare data. Cohorts from England, Scotland, and Wales were transformed despite substantial heterogeneity in data structure, coding systems, and variable definitions. The resulting harmonised resource preserves each cohort as an independent dataset while enabling federated analyses to be conducted across sites without the need to share individual-level data. Collectively, the cohorts capture over 17.5 million live births, providing sufficient scale to investigate rare exposures and outcomes, support trial emulation, and evaluate population-level policy impacts across the UK. This article details the transformation pipeline and provides reusable methods to support extension to additional cohorts and networks. The harmonised datasets enable interoperable, reproducible research and facilitate cross-national comparative studies in maternal and child health.
Open AccessMother-infant linked UK electronic birth cohorts representing 17.5 million births harmonised to the OMOP common data model
We describe the harmonisation of five UK electronic birth cohorts to the Observational Medical Outcomes Partnership (OMOP) Common Data Model, creating a large-scale, standardised resource for maternal and child health research. The Mother and Infant Research Data Analysis (MIREDA) partnership developed and implemented reproducible guidelines for mapping maternal–infant relationships and identifying pregnancy episodes within routinely collected healthcare data. Cohorts from England, Scotland, and Wales were transformed despite substantial heterogeneity in data structure, coding systems, and variable definitions. The resulting harmonised resource preserves each cohort as an independent dataset while enabling federated analyses to be conducted across sites without the need to share individual-level data. Collectively, the cohorts capture over 17.5 million live births, providing sufficient scale to investigate rare exposures and outcomes, support trial emulation, and evaluate population-level policy impacts across the UK. This article details the transformation pipeline and provides reusable methods to support extension to additional cohorts and networks. The harmonised datasets enable interoperable, reproducible research and facilitate cross-national comparative studies in maternal and child health.
- Open Access
- 31 December 2025
- Published by Elsevier in Artificial Intelligence in Medicine
- Vol. 173, 103346
Learning Health Systems provide a glide path to safe landing for AI in health
- 31 December 2025
- Published by Elsevier in Artificial Intelligence in Medicine
- Vol. 173, 103346
Open AccessLearning Health Systems provide a glide path to safe landing for AI in health
- Open Access
- 9 December 2025
- Published by Wiley
Trends in the Incidence and Risk of Ectopic Pregnancy: A UK Electronic-Record Cohort Study of 4.6 million pregnancies
Objective: To describe trends in the epidemiology of ectopic pregnancy in the UK, and to identify changing trends in ectopic pregnancies among women in different age groups. Design: Electronic health record cohort study using linked primary and secondary care data between 2000 and 2023. Setting: United Kingdom Population: Women registered in general practices contributing to Clinical Practice Research Datalink (CPRD) Aurum Methods: We identified pregnancies in CPRD and Hospital Episodes Statistics data. We calculated incidence of first ectopic pregnancy among women and of ectopic pregnancies as a proportion of observed births. We modelled missing pregnancies in the data to estimate the true risk of ectopic pregnancies, and fitted logistic regression models to estimate association with known risk factors. Main Outcome Measures: Risk of ectopic pregnancy Results: 12,922,751 women and 4,601,882 pregnancies were included. The highest incidence burden of ectopic pregnancy was among women aged 30-39. The risk of a pregnancy being diagnosed as ectopic among women of all ages is 1.78 times higher in 2022 compared with 2010 (95% Confidence Interval 1.76, 1.79) and is especially pronounced among women aged 40-50 (Risk ratio: 2.2 [95% CI 2.09, 2.32]). Birth outcomes were missing in 34% of pregnancies. Conclusions: Rates of ectopic pregnancy have risen in recent years and although better detection may be a factor, other drivers such as rising Pelvic Inflammatory Disease rates must be mitigated to prevent additional morbidity and fertility loss. Funding: This project received funding from the University of Birmingham. Keywords : Ectopic Pregnancy; Electronic Health Records; maternal health
- 9 December 2025
- Published by Wiley
Open AccessTrends in the Incidence and Risk of Ectopic Pregnancy: A UK Electronic-Record Cohort Study of 4.6 million pregnancies
Objective: To describe trends in the epidemiology of ectopic pregnancy in the UK, and to identify changing trends in ectopic pregnancies among women in different age groups. Design: Electronic health record cohort study using linked primary and secondary care data between 2000 and 2023. Setting: United Kingdom Population: Women registered in general practices contributing to Clinical Practice Research Datalink (CPRD) Aurum Methods: We identified pregnancies in CPRD and Hospital Episodes Statistics data. We calculated incidence of first ectopic pregnancy among women and of ectopic pregnancies as a proportion of observed births. We modelled missing pregnancies in the data to estimate the true risk of ectopic pregnancies, and fitted logistic regression models to estimate association with known risk factors. Main Outcome Measures: Risk of ectopic pregnancy Results: 12,922,751 women and 4,601,882 pregnancies were included. The highest incidence burden of ectopic pregnancy was among women aged 30-39. The risk of a pregnancy being diagnosed as ectopic among women of all ages is 1.78 times higher in 2022 compared with 2010 (95% Confidence Interval 1.76, 1.79) and is especially pronounced among women aged 40-50 (Risk ratio: 2.2 [95% CI 2.09, 2.32]). Birth outcomes were missing in 34% of pregnancies. Conclusions: Rates of ectopic pregnancy have risen in recent years and although better detection may be a factor, other drivers such as rising Pelvic Inflammatory Disease rates must be mitigated to prevent additional morbidity and fertility loss. Funding: This project received funding from the University of Birmingham. Keywords : Ectopic Pregnancy; Electronic Health Records; maternal health
- Top Cited PapersOpen Access
- 7 February 2025
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 27 (1) , e62763
Understanding “Alert Fatigue” in Primary Care: Qualitative Systematic Review of General Practitioners Attitudes and Experiences of Clinical Alerts, Prompts, and Reminders
Background: The consistency and quality of care in modern primary care are supported by various clinical reminders (CRs), which include “alerts” describing the consequences of certain decisions and “prompts” that remind users to perform tasks promoting desirable clinical behaviors. However, not all CRs are acted upon, and many are disregarded by general practitioners (GPs), a chronic issue commonly referred to as “alert fatigue.” This phenomenon has significant implications for the safety and quality of care, GP burnout, and broader medicolegal consequences. Research on mitigating alert fatigue and optimizing the use of CRs remains limited. This review offers much-needed insight into GP attitudes toward the deployment, design, and overall effectiveness of CRs. Objective: This systematic review aims to synthesize current qualitative research on GPs’ attitudes toward CRs, enabling an exploration of the interacting influences on the occurrence of alert fatigue in GPs, including the deployment, design, and perceived efficacy of CRs. Methods: A systematic literature search was conducted across the Health Technology Assessment database, MEDLINE, MEDLINE In-Process, Embase, CINAHL, Conference Proceedings Citation Index, PsycINFO, and OpenGrey. The search focused on primary qualitative and mixed methods research conducted in general or family practice, specifically exploring GPs’ experiences with CRs. All databases were searched from inception to December 31, 2023. To ensure structured and practicable findings, we used a directed content analysis of the data, guided by the 7 domains of the Non-adoption, Abandonment, Scale-up, Spread, and Sustainability (NASSS) framework, including domains related to Technology, Adopter attitudes, and Organization. Results: A total of 9 studies were included, and the findings were organized within the 7 domains. Regarding Condition and Value Proposition, GPs viewed CRs as an effective way to maintain or improve the safety and quality of care they provide. When considering the attributes of the Technology, the efficacy of CRs was linked to their frequency, presentation, and the accuracy of their content. Within Adopters, concerns were raised about the accuracy of CRs and the risk that their use could diminish the value of GP experience and contextual understanding. From an Organization perspective, the need for training on the use and benefits of CRs was highlighted. Finally, in the context of the Wider system and their Embedding Over Time, suggestions included sharing best practices for CR use and involving GPs in their design. Conclusions: While GPs acknowledged that CRs, when used optimally, can enhance patient safety and quality of care, several concerns emerged regarding their design, content accuracy, and lack of contextual nuance. Suggestions to improve CR adherence included providing coherent training, enhancing their design, and incorporating more personalized content. Trial Registration: PROSPERO CRD42016029418; https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=29418 International Registered Report Identifier (IRRID): RR2-10.1186/s13643-017-0627-z
- 7 February 2025
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 27 (1) , e62763
Top Cited PapersOpen AccessUnderstanding “Alert Fatigue” in Primary Care: Qualitative Systematic Review of General Practitioners Attitudes and Experiences of Clinical Alerts, Prompts, and Reminders
Background: The consistency and quality of care in modern primary care are supported by various clinical reminders (CRs), which include “alerts” describing the consequences of certain decisions and “prompts” that remind users to perform tasks promoting desirable clinical behaviors. However, not all CRs are acted upon, and many are disregarded by general practitioners (GPs), a chronic issue commonly referred to as “alert fatigue.” This phenomenon has significant implications for the safety and quality of care, GP burnout, and broader medicolegal consequences. Research on mitigating alert fatigue and optimizing the use of CRs remains limited. This review offers much-needed insight into GP attitudes toward the deployment, design, and overall effectiveness of CRs. Objective: This systematic review aims to synthesize current qualitative research on GPs’ attitudes toward CRs, enabling an exploration of the interacting influences on the occurrence of alert fatigue in GPs, including the deployment, design, and perceived efficacy of CRs. Methods: A systematic literature search was conducted across the Health Technology Assessment database, MEDLINE, MEDLINE In-Process, Embase, CINAHL, Conference Proceedings Citation Index, PsycINFO, and OpenGrey. The search focused on primary qualitative and mixed methods research conducted in general or family practice, specifically exploring GPs’ experiences with CRs. All databases were searched from inception to December 31, 2023. To ensure structured and practicable findings, we used a directed content analysis of the data, guided by the 7 domains of the Non-adoption, Abandonment, Scale-up, Spread, and Sustainability (NASSS) framework, including domains related to Technology, Adopter attitudes, and Organization. Results: A total of 9 studies were included, and the findings were organized within the 7 domains. Regarding Condition and Value Proposition, GPs viewed CRs as an effective way to maintain or improve the safety and quality of care they provide. When considering the attributes of the Technology, the efficacy of CRs was linked to their frequency, presentation, and the accuracy of their content. Within Adopters, concerns were raised about the accuracy of CRs and the risk that their use could diminish the value of GP experience and contextual understanding. From an Organization perspective, the need for training on the use and benefits of CRs was highlighted. Finally, in the context of the Wider system and their Embedding Over Time, suggestions included sharing best practices for CR use and involving GPs in their design. Conclusions: While GPs acknowledged that CRs, when used optimally, can enhance patient safety and quality of care, several concerns emerged regarding their design, content accuracy, and lack of contextual nuance. Suggestions to improve CR adherence included providing coherent training, enhancing their design, and incorporating more personalized content. Trial Registration: PROSPERO CRD42016029418; https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=29418 International Registered Report Identifier (IRRID): RR2-10.1186/s13643-017-0627-z
- Open Access
- 5 September 2024
- Published by Elsevier in eClinicalMedicine
- Vol. 76, 102822
Clinical decision support systems for maternity care: a systematic review and meta-analysis
- 5 September 2024
- Published by Elsevier in eClinicalMedicine
- Vol. 76, 102822
Open AccessClinical decision support systems for maternity care: a systematic review and meta-analysis
- Open Access
- 4 July 2024
- Published by Springer Nature in BMC Medical Research Methodology
- Vol. 24 (1) , 1-7
Automating incidence and prevalence analysis in open cohorts
Motivation: Data is increasingly used for improvement and research in public health, especially administrative data such as that collected in electronic health records. Patients enter and exit these typically open-cohort datasets non-uniformly; this can render simple questions about incidence and prevalence time-consuming and with unnecessary variation between analyses. We therefore developed methods to automate analysis of incidence and prevalence in open cohort datasets, to improve transparency, productivity and reproducibility of analyses. Implementation: We provide both a code-free set of rules for incidence and prevalence that can be applied to any open cohort, and a python Command Line Interface implementation of these rules requiring python 3.9 or later. General features: The Command Line Interface is used to calculate incidence and point prevalence time series from open cohort data. The ruleset can be used in developing other implementations or can be rearranged to form other analytical questions such as period prevalence. Availability: The command line interface is freely available from https://github.com/THINKINGGroup/analogy_publication.
- 4 July 2024
- Published by Springer Nature in BMC Medical Research Methodology
- Vol. 24 (1) , 1-7
Open AccessAutomating incidence and prevalence analysis in open cohorts
Motivation: Data is increasingly used for improvement and research in public health, especially administrative data such as that collected in electronic health records. Patients enter and exit these typically open-cohort datasets non-uniformly; this can render simple questions about incidence and prevalence time-consuming and with unnecessary variation between analyses. We therefore developed methods to automate analysis of incidence and prevalence in open cohort datasets, to improve transparency, productivity and reproducibility of analyses. Implementation: We provide both a code-free set of rules for incidence and prevalence that can be applied to any open cohort, and a python Command Line Interface implementation of these rules requiring python 3.9 or later. General features: The Command Line Interface is used to calculate incidence and point prevalence time series from open cohort data. The ruleset can be used in developing other implementations or can be rearranged to form other analytical questions such as period prevalence. Availability: The command line interface is freely available from https://github.com/THINKINGGroup/analogy_publication.
- Open Access
Maternal and Infant Research Electronic Data Analysis (MIREDA): A protocol for creating a common data model for federated analysis of UK birth cohorts and the life course
Introduction Birth cohorts are valuable resources for studying early life, the determinants of health, disease, and development. They are essential for studying life course. Electronic cohorts are live, dynamic longitudinal cohorts using anonymised, routinely collected data. There is no selection bias through direct recruitment, but they are limited to health and administrative system data and may lack contextual information. The MIREDA (Maternal and Infant Research Electronic Data Analysis) partnership creates a UK-wide birth cohort by aligning existing electronic birth cohorts to have the same structure, content, and vocabularies, enabling UK-wide federated analyses. Objectives Create a core dynamic, live UK-wide electronic birth cohort with approximately 100,000 new births per year using a common data model (CDM). Provide data linkage and automation for long-term follow up of births from MuM-PreDiCT and the ‘Born in’ initiatives of Bradford, Wales, Scotland, and South London for comparable analyses. Methods We will establish core data content and collate linkable data. Use a suite of extraction, transformation, and load (ETL) tools will be used to transform the data for each birth cohort into the CDM. Transformed datasets will remain within each cohort’s trusted research environment (TRE). Metadata will be uploaded for the public to the Health Data Research (HDRUK) Innovation Gateway. We will develop a single online data access request for researchers. A cohort profile will be developed for researchers to reference the resource. Ethics Each cohort has approval from their TRE through compliance with their project application processes and information governance. Dissemination We will engage with researchers in the field to promote our resource through partnership networking, publication, research collaborations, conferences, social media, and marketing communications strategies.
Open AccessMaternal and Infant Research Electronic Data Analysis (MIREDA): A protocol for creating a common data model for federated analysis of UK birth cohorts and the life course
Introduction Birth cohorts are valuable resources for studying early life, the determinants of health, disease, and development. They are essential for studying life course. Electronic cohorts are live, dynamic longitudinal cohorts using anonymised, routinely collected data. There is no selection bias through direct recruitment, but they are limited to health and administrative system data and may lack contextual information. The MIREDA (Maternal and Infant Research Electronic Data Analysis) partnership creates a UK-wide birth cohort by aligning existing electronic birth cohorts to have the same structure, content, and vocabularies, enabling UK-wide federated analyses. Objectives Create a core dynamic, live UK-wide electronic birth cohort with approximately 100,000 new births per year using a common data model (CDM). Provide data linkage and automation for long-term follow up of births from MuM-PreDiCT and the ‘Born in’ initiatives of Bradford, Wales, Scotland, and South London for comparable analyses. Methods We will establish core data content and collate linkable data. Use a suite of extraction, transformation, and load (ETL) tools will be used to transform the data for each birth cohort into the CDM. Transformed datasets will remain within each cohort’s trusted research environment (TRE). Metadata will be uploaded for the public to the Health Data Research (HDRUK) Innovation Gateway. We will develop a single online data access request for researchers. A cohort profile will be developed for researchers to reference the resource. Ethics Each cohort has approval from their TRE through compliance with their project application processes and information governance. Dissemination We will engage with researchers in the field to promote our resource through partnership networking, publication, research collaborations, conferences, social media, and marketing communications strategies.